Ferring would like to use cookies to better understand your use of this website and improve your experience while navigating it. Please accept our use of cookies in accordance with our privacy policy

Accept / Decline

Press releases

Jens Peter Nørgaard awarded prestigious professorship at University of Lund

Copenhagen, 28 April 2005 - Jens Peter Nørgaard, Ferring's chief scientific officer for urology in clinical research and development, has been awarded the prestigious Adjunct Professorship of Urology at the University of Lund, Sweden.

Jens Peter, who has specialised in urology and paediatric surgery since qualifying as a medical doctor in 1981, will combine the professorship with his current role at Ferring in Copenhagen, where he has worked since 1997.

Jens Peter is one of the most respected names in the field of urology and completed a thesis on primary nocturnal enuresis in 1990 which has been widely published and referenced in the field. He was also founder of the International Children's Continence Society (ICCS) and continues as an active member of this organisation.

Anders Mattiasson, Professor of Urology at Lund University welcomed the appointment, commenting that "Jens Peter has an excellent reputation in the field of urology and we look forward to working closely with him.

"It is the fulfilment of a long and fruitful partnership between the university's urology department and Ferring," he added "and it supports the Medicon Valley Academy's objective of building bridges between the pharmaceutical industry, academia and hospitals."

Pascal Danglas, Ferring's executive vice president of clinical and product development, echoed Professor Mattiasson's views. "We have had an excellent relationship with the University for many years, and we are enthusiastic about the contribution Jens Peter can make in bringing closer cooperation between the industry, universities and the public health sector."

About Ferring:
Ferring is a Swiss-based research driven, speciality biopharmaceutical group active in global markets.
The company identifies, develops and markets innovative products in the areas of endocrinology, gastroenterology, gynaecology, infertility and urology.

In recent years Ferring has expanded beyond its traditional European base and now has operating subsidiaries in over 40 countries.

To learn more about Ferring or our products please visit us at www.ferring.com

Michael George
Corporate Communication Manager
Tel.: +45 2878 72 09




See more Press releases



TEL:  +41 58 301 00 00
FAX: +41 58 301 00 10


Global Locator